JNJ.HM Johnson & Johnson
- Market cap
- -
- P/E
- 42.2x
- P/B
- 7.88x
- ROE
- 18.0%
- Dividend yield
- 2.24%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is JNJ.HM undervalued?
Graham numberThe Graham number of Johnson & Johnson cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Johnson & Johnson fundamental analysis
No fundamental analysis for Johnson & Johnson yet.
Johnson & Johnson stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Johnson & Johnson financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Johnson & Johnson annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 71.9B | 76.5B | 81.6B | 82.1B | 82.6B | 78.7B | 94.9B | 85.2B | 88.8B | 94.2B | 99.7B |
| Gross Profit | 50.2B | 51.1B | 54.5B | 54.5B | 54.2B | 55.3B | 63.9B | 58.6B | 61.4B | 63.9B | 67.4B |
| Operating Income | 21.1B | 18.7B | 20.0B | 20.1B | 19.7B | 20.9B | 23.7B | 22.0B | 21.2B | 25.6B | 26.6B |
| EBITDA | - | 24.2B | 25.9B | 24.7B | 19.9B | 24.5B | 26.6B | 23.3B | 24.8B | 41.1B | 26.2B |
| Net Income | 16.5B | 1.30B | 15.3B | 15.1B | 14.7B | 20.9B | 17.9B | 35.2B | 14.1B | 26.8B | 14.6B |
| EPS | - | 0.48 | 5.75 | 5.74 | 5.59 | 7.94 | 6.86 | 15 | 5.84 | 11 | 6.08 |
| Balance Sheet | |||||||||||
| Total Assets | 141B | 157B | 153B | 158B | 175B | 182B | 187B | 168B | 180B | 199B | 197B |
| Total Liabilities | 70.8B | 97.1B | 93.2B | 98.3B | 112B | 108B | 111B | 98.8B | 109B | 118B | 116B |
| Shareholders' Equity | 70.4B | 60.2B | 59.8B | 59.5B | 63.3B | 74.0B | 76.8B | 68.8B | 71.5B | 81.5B | 81.5B |
| Cash & Short-term Investments | 19.0B | 17.8B | 18.1B | 17.3B | 14.0B | 14.5B | 12.9B | 21.9B | 24.1B | 19.7B | 16.9B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 18.8B | 21.1B | 22.2B | 23.4B | 23.5B | 23.4B | 21.2B | 22.8B | 24.3B | 24.5B | 25.1B |
| Capital Expenditure | 3.23B | 3.28B | 3.67B | 3.50B | 3.35B | 3.65B | 4.01B | 5.01B | 6.21B | 5.22B | 6.30B |
| Free Cash Flow | - | 17.8B | 18.5B | 19.9B | 20.2B | 19.8B | 17.2B | 17.8B | 18.1B | 19.3B | 18.8B |
| Ratios | |||||||||||
| ROE | 23.5% | 2.2% | 25.6% | 25.4% | 23.3% | 28.2% | 23.4% | 51.1% | 19.7% | 32.9% | 18.0% |
| ROA | 11.7% | 0.8% | 10.0% | 9.6% | 8.4% | 11.5% | 9.6% | 21.0% | 7.8% | 13.5% | 7.4% |
| Net Profit Margin | 23.0% | 1.7% | 18.8% | 18.4% | 17.8% | 26.5% | 18.9% | 41.3% | 15.8% | 28.5% | 14.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Johnson & Johnson dividends
- Dividend yield
- 2.24%
- Forward dividend
- -
- Payout ratio
- 46.2%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 12.4B | 5.14 | 46.2% |
| 2024 | USD 11.8B | 4.91 | 84.1% |
| 2023 | USD 11.8B | 4.89 | 33.5% |
| 2022 | USD 11.7B | 4.47 | 65.1% |
| 2021 | USD 11.0B | 4.20 | 52.8% |
| 2020 | USD 10.5B | 3.98 | 71.2% |
| 2019 | USD 9.92B | 3.77 | 65.6% |
| 2018 | USD 9.49B | 3.57 | 62.1% |
| 2017 | USD 8.94B | 3.33 | 687.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 13, 2001.
Who owns Johnson & Johnson
Ownership data of Johnson & Johnson is not available yet.
Johnson & Johnson company profile
- Company name
- Johnson & Johnson
- Ticker
- JNJ.HM
- Exchange
- Hamburg Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- Website
- -
About Johnson & Johnson
There is no Profile data available for JNJ.HM.